AGLink® ADC Conjugation Kit (MMAE, DAR2&4,1mg)
AGLink® ADC Conjugation Kit (MMAE, DAR2&4,1mg)
Product Specifications
Background
Antibody-drug conjugates (ADC) is a type of fast growing anticancer drug. Monoclonal antibody is conjugated to the cytotoxic payload via a chemical linker that directed toward a target antigen expressed on the cancer cell surface, reducing systemic exposure and therefore toxicity. AGLink® ADC conjugation kit is designed to conjugate mAb with toxic payload (MMAE) though site-specific enzymatic reaction.
Target
MMAE
Applications
AGLink® ADC Conjugation Kit (MMAE, DAR2&4,1mg) is designed to conjugate 1mg mAb with toxic payload (MMAE) through site-specific enzymatic reaction.
Stability
BoxA: The unopened kit is stable for 12 months from the date of manufacture if stored under temperature ≤ -20°C. The opened kit should be stored according to components table. BoxB: The unopened kit is stable for 12 months from the date of manufacture if stored under 4°C. The opened kit should be stored according to components table.
Format
Solid
Shipping Conditions
Blue ice
Storage Conditions
-20°C
Package Size
1Reaction*1
Product Datasheet
Https://www.acrobiosystems.com/static/main/products/pdf/ds/ADC-P005.pdf
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
